European expansion CoreFX is expanding into Europe with a new European headquarters in Ireland and R&D collaboration with Teagasc Moorepark, backed by Enterprise Ireland funding. This signals a growing need for regional supply, co-development opportunities, and localized regulatory support for customers in the EU.

bioavailability focus The CoreNhanced platform along with eXoFunction and BioTransport technologies emphasizes improved nutrient delivery and stability. This presents a clear value proposition for brands seeking higher bioavailability, cleaner labels, and consistent performance in finished products.

tech-enabled partnerships A tech-forward stack and agile platforms underpin CoreFX’s ability to customize spray drying, encapsulation, and timed-release solutions. Potential sales opportunities exist in collaborating on product innovations that require scalable manufacturing and precise nutrient release profiles.

recognition signal Industry accolades such as Manufacturer of the Year and Best & Brightest Companies to Work For enhance credibility with potential partners and retailers, enabling easier outreach and higher trust in co-development and supply arrangements.

mid-market focus With 51-200 employees and annual revenue in the $50M-$100M range, CoreFX presents a mid-market profile that can be a strong partner for growth-oriented brands seeking specialized, high-performance nutritional ingredients and flexible manufacturing capabilities without large enterprise commitments.